ATLANTA, Aug. 16 (dbusiness)--CryoLife Inc. (NYSE:CRY) is going European.
The Atlanta company, which makes medical devices and surgical adhesives, announced early today that it will soon open a European headquarters near London, CryoLife Europa Ltd.
The company entered the European market three years ago, introducing the CryoLife-O'Brien porcine heart valve. It introduced a second product, the CryoLife-Ross porcine heart valve, in Europe last year. In April of last year, the company received approval to distribute its BioGlue surgical adhesive, used in vascular repair.
European revenues made up about 3 percent of the company's total revenues during the first six months of this year, reaching $900,000 by June 30.